SEC Form 4 · accession 0001209191-19-002774
Alaunos Therapeutics, Inc. · TCRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David M Mauney M.D.
Officer — President
Period of report
Jan 6, 2019
Accepted (ET)
Jan 8, 2019 · 4:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001107421
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 6, 2019 | A | 159,010 | $0.00 | A | 217,672 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $2.24 | Jan 6, 2019 | A | 250,733 | A | — | Jan 6, 2029 | Common Stock | 250,733 | 250,733 | D |
Explanation of responses
- F153,004 shares shall vest on 12/31/2019 and 53,033 shares shall vest on each of 12/31/2020 and 12/31/2021.
- F21/12th of the shares underlying this option will vest in equal quarterly installments commencing one quarterly period after 12/31/2018.